Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2009
06/03/2009CN100494389C Needle-like microelectrode for karyon transplanting/ clonal electrical fusion
06/03/2009CN100494388C Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
06/03/2009CN100494387C Method for increasing catharanthus roseus hairy root terpenes indole alkaloid content
06/03/2009CN100494386C Method for yeast cell to express human interleukin 10
06/03/2009CN100494385C Constructing method for transgenic Chlamydomonas reinhardtii bioreactor
06/03/2009CN100494384C T vector and its construction method
06/03/2009CN100494383C Thermophilic heat resisting dextran phosphorylase preparation process
06/03/2009CN100494382C Sucrose synthase gene of cotton
06/03/2009CN100494381C Chimeric antigen gene of hepatitis B and hepatitis C and its nucleic acid vaccine
06/03/2009CN100494380C A nucleodite sequence of anti-hepatitis virus C infection and preventing and curing hepatitis virus C and its fragment and application
06/03/2009CN100494379C Paddy hpfr gene, expression product and application thereof
06/03/2009CN100494378C Transgenic organism expressing fungal MRP-like ABC transporters
06/03/2009CN100494377C Gene sequence for specificly expressing human granulocyte macrophage colony stimulus factor
06/03/2009CN100494376C Recombinant human esoderma colyone adenovirus, and its preparing method and use
06/03/2009CN100494375C Cloning for pig immunity character related gene PSMB6 and its use
06/03/2009CN100494374C Method of continuously extracting large quantity plasmid
06/03/2009CN100494373C Method for preserving sample of nucleic acid
06/03/2009CN100494372C Method of culturing anti-adverse environment transgenic tobacco
06/03/2009CN100494371C Method for cultivating adverse environment-resistant transgenic rice
06/03/2009CN100494370C Optimized monoclonal antibody
06/03/2009CN100494369C Method for obtaining Tibetan Sinopodophyllum hexandrum hairy root which produce podophyllotoxin through agrobacterium rhizogenes genetic transformation, and its product
06/03/2009CN100494363C Glycooxidase and its application in baking process
06/03/2009CN100494344C New biopesticide using gene from erwinia pyrifoliaeWT#3, novel pathogen that affects asian pear trees
06/03/2009CN100494213C Process for preparing synergistic factor in artificial blood, nucleotide sequence used thereby
06/03/2009CN100493693C Apparatus for treatment of light-sensitive biopolymers
06/03/2009CN100493618C Series non-virus vector, and medicinal composition containing same
06/03/2009CN100493617C Recombinant adeno-associated virus for prevention and cure of I-type diabetes and use thereof
06/02/2009US7541520 Soybean variety XB47Q06
06/02/2009US7541519 Fatty acid desaturases and mutant sequences thereof
06/02/2009US7541517 Bacillus thuringiensis CRY9 nucleic acids
06/02/2009US7541516 introducing into progenitor cells of the plant a plant transformation vector comprising a heterologous constitutive promoter operatively linked to a nucleotide sequence that encodes a HIO32.2 polypeptide, growing the cell to produce transgenic plant with an altered oil content phenotype
06/02/2009US7541515 Method of increasing expression of heterologous proteins in plants
06/02/2009US7541513 Mouse λ light chain locus
06/02/2009US7541512 Avians containing a lysozyme promoter transgene
06/02/2009US7541511 Mouse exhibiting characteristics of Rothmund-Thomson syndrome and preparation method thereof
06/02/2009US7541491 Gene involved in growth-promoting function of acetic acid bacteria and uses thereof
06/02/2009US7541453 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response
06/02/2009US7541452 Monocotyledon promoter sequences for use as tools to enhance heterologous gene expression in plants
06/02/2009US7541450 producing the hybrid proteins comprising a single polypeptide having a target protein with a ligand-dependent intein embedded in the sequence of target proteins; modulation of protein activity; molecular switches
06/02/2009US7541449 DNA segment encoding the enzyme inhibitor for therapy of thrombosis, blood disorders; biodrugs; genetic vaccines; monoclonal antibodies; host cells
06/02/2009US7541448 Oligonucleotides containing molecular rods
06/02/2009US7541446 Transcriptional activator fusion proteins which comprises both tetracycline controlled transactivator proteins and reverse tetracycline transactivator proteins
06/02/2009US7541443 A humanized antibody for use as immunosuppressants, treating or preventing transplant rejection in human patient; drug screening
06/02/2009US7541440 Invention provides monoclonal antibody or fragment thereof that binds granulocyte (neutrophil) antigen, preferably provides humanized, chimeric and human anti-granulocyte-targeting antibodies, such as MN3 antibodies, useful for treatment and diagnosis of malignancy diseases resulting from ischemic injury
06/02/2009US7541439 Thrombopoietin proteins with improved properties
06/02/2009US7541438 Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
06/02/2009US7541437 Breast cancer resistance protein (BCRP) and the DNA which encode it
06/02/2009US7541435 Antagonists of cxcr3-binding cxc chemokines
06/02/2009US7541434 Polypeptide for a TRP channel family member, TRP-PLIK2, and splice variants
06/02/2009US7541433 Transformed plant or fish cells with the isolated polynucleotide; wider array of colors and biochemical features compared to existing wild-type green fluorescent protein
06/02/2009US7541432 L-glutamate-gated chloride channel proteins from Rhipicephalus sanguineus
06/02/2009US7541429 Comparative ligand mapping from MHC positive cells
06/02/2009US7541428 Tumor antigen protein SART-3 and tumor antigen peptides thereof
06/02/2009US7541344 Modulation of survivin expression
06/02/2009US7541343 Antiproliferative agents; administering protein; restenosis, atherosclerosis; cancer
06/02/2009US7541337 Methods and compositions for the treatment of peripheral artery disease
06/02/2009US7541335 Nogo-receptors and methods of use
06/02/2009US7541333 Angiogenically effective unit dose of FGF-2 and method of use
06/02/2009US7541195 Substrate for biomolecule microarray, biomolecule microarray, device and method of promoting interaction, and method of detecting interaction
06/02/2009US7541193 Caged sensors, regulators and compounds and uses thereof
06/02/2009US7541189 complex of a certain ARNT family transcription coupling factor and a certain transcription regulatory factor with ability of exerting a promotive activity on the CME sequence; Down's syndrome
06/02/2009US7541188 Comprising BSA, isoproterenol, carnitine, serine, oleic acid, linoleic acid, arachidonic acid, alpha -tocopherol, ascorbic acid, and EGF; for irritancy testing
06/02/2009US7541183 Growth and differentiation of adult muscle stem cells with activators or inhibitors of Wnt signaling
06/02/2009US7541181 Vector carrying a polynucleotide which encodes a GSD polypeptide from Mycobacterium paratuberculosis
06/02/2009US7541180 comprising administering to a cells or tissues in vitro; hepatitis C virus (HCV) antigens; dna immunization
06/02/2009US7541179 Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies
06/02/2009US7541174 Bacterial host cell for the direct expression of peptides
06/02/2009US7541172 DNA sequence encoding a polypeptide having the biological activity of amorpha-4,11-diene synthase, which is used to produce the specific precursor in the synthesis of artemisinin
06/02/2009US7541171 Halohydrin dehalogenases and related polynucleotides
06/02/2009US7541170 Binding; amplification of nucleotide sequences; fusion proteins
06/02/2009US7541168 Recombinant cyclopentanone monooxygenase [cpmo]
06/02/2009US7541163 Expression vector comprising nucleotide sequences coding multifunctional protein with viricidal activity
06/02/2009US7541158 Canine Tas1r1, Tas1r2, and Tas1r3 receptor genes; screening for compounds that modify the genes' function or activity; modifying taste preferences, ingestive responses, or general behavior of a mammal such as a dog by administering compounds that affect the function or activity of the gene
06/02/2009US7541154 GASP1: a follistatin domain containing protein
06/02/2009US7541153 Screening a substance interfering in the association of Dedicator of cytokinesis 2 (DOCK2) and engulfment and cell motility 1(ELMO1); drug screening; allergy, autoimmune diseases, GvH, graft rejection
06/02/2009US7541151 Single-cell biosensor for the measurement of GPCR ligands in a test sample
06/02/2009US7541148 A primer for analyzing gene mutation having a primer binding sequence 1 and 2 and, a restriction enzyme recognition sequence wherein single stranded polynucleotide fragments of 2-32 bases are produced by amplifying with the primer and cleaved by the restriction enzymes; medical diagnosis; accuracy
06/02/2009US7541147 Materials and methods for detection of nucleic acids
06/02/2009US7541145 Cleavage of nucleic acids
06/02/2009US7541143 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
06/02/2009US7541142 Protein useful for diagnosis, cancer therapy
06/02/2009US7541139 Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins
06/02/2009US7541039 Vaccine delivery; attaching immunogenic determinant of heterologous polypeptide biodrug to the peptidoglycan microparticle on cell wall of a Gram-positive bacterium; improve the binding by treating the cell wall with acid solution to remove protein, lipotechoic, carbohydrates
06/02/2009US7541038 Fusogenic, self-propagating blebs as immunogenic compositions
06/02/2009US7541034 Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors
06/02/2009US7541033 Humanized anti-IL-1β antibodies
06/02/2009US7541031 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα
06/02/2009US7541029 Anti-rhesus D monoclonal antibodies
06/02/2009CA2480564C Novel root-knot nematode-resistance gene and application thereof
06/02/2009CA2395364C Model animal with onset of collagen-induced arthritis
06/02/2009CA2340416C Co-lyophilized complex of a nucleic acid vector and a formulating agent
06/02/2009CA2339089C Cold-adapted equine influenza viruses
06/02/2009CA2321664C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/02/2009CA2285919C Diagnostic tests and kits for clostridium difficile
06/02/2009CA2274495C Uspa1 and uspa2 antigens of moraxella catarrhalis
06/02/2009CA2267101C Thermostable nucleic acid polymerase from thermococcus gorgonarius
06/02/2009CA2235419C Microorganisms and processes for the fermentative preparation of l-cysteine, l-cystine, n-acetylserine or thiazolidine derivatives
06/02/2009CA2068863C Particle-mediated transformation of animal tissue cells
05/2009
05/30/2009CA2618374A1 Trimeric collagen scaffold antibodies
05/28/2009WO2009067581A1 Nucleotide sequence of shrimp actin promoter and its use